Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.

Lew RM, Burnett L, Proos AL, Barlow-Stewart K, Delatycki MB, Bankier A, Aizenberg H, Field MJ, Berman Y, Fleischer R, Fietz M.

J Paediatr Child Health. 2015 Mar;51(3):271-9. doi: 10.1111/jpc.12632. Epub 2014 Jun 13. Review.

PMID:
24923490
2.

Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.

Lew RM, Proos AL, Burnett L, Delatycki M, Bankier A, Fietz MJ.

Med J Aust. 2012 Dec 10;197(11):652-4.

PMID:
23230938
3.
4.
5.

Heterozygote screening for Tay-Sachs disease: past successes and future challenges.

Natowicz MR, Prence EM.

Curr Opin Pediatr. 1996 Dec;8(6):625-9. Review.

PMID:
9018448
7.

Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure.

Bach G, Tomczak J, Risch N, Ekstein J.

Am J Med Genet. 2001 Feb 15;99(1):70-5.

PMID:
11170098
8.
9.
10.

Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.

Broide E, Zeigler M, Eckstein J, Bach G.

Am J Med Genet. 1993 Aug 15;47(2):213-5.

PMID:
8213907
11.
12.

ACOG committee opinion. Number 318, October 2005. Screening for Tay-Sachs disease.

ACOG Committee on Genetics.

Obstet Gynecol. 2005 Oct;106(4):893-4.

PMID:
16199656
13.

Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.

Schneider A, Nakagawa S, Keep R, Dorsainville D, Charrow J, Aleck K, Hoffman J, Minkoff S, Finegold D, Sun W, Spencer A, Lebow J, Zhan J, Apfelroth S, Schreiber-Agus N, Gross S.

Am J Med Genet A. 2009 Nov;149A(11):2444-7. doi: 10.1002/ajmg.a.33085.

PMID:
19876898
14.

Prenatal genetic carrier testing using triple disease screening.

Eng CM, Schechter C, Robinowitz J, Fulop G, Burgert T, Levy B, Zinberg R, Desnick RJ.

JAMA. 1997 Oct 15;278(15):1268-72.

PMID:
9333269
15.

The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin.

Petersen GM, Rotter JI, Cantor RM, Field LL, Greenwald S, Lim JS, Roy C, Schoenfeld V, Lowden JA, Kaback MM.

Am J Hum Genet. 1983 Nov;35(6):1258-69.

16.

Tay-Sachs disease carrier screening: a 21-year experience.

D'Souza G, McCann CL, Hedrick J, Fairley C, Nagel HL, Kushner JD, Kessel R.

Genet Test. 2000;4(3):257-63.

PMID:
11142756
17.

Tay-Sachs disease as a model for screening inborn errors.

Blitzer MG, McDowell GA.

Clin Lab Med. 1992 Sep;12(3):463-80. Review.

PMID:
1355703
18.

Evaluation of a Tay-Sachs disease screening program.

Gason AA, Sheffield E, Bankier A, Aitken MA, Metcalfe S, Barlow Stewart K, Delatycki MB.

Clin Genet. 2003 May;63(5):386-92.

PMID:
12752571
19.

Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.

Ioannou L, Massie J, Lewis S, Petrou V, Gason A, Metcalfe S, Aitken MA, Bankier A, Delatycki MB.

Clin Genet. 2010 Jul;78(1):21-31. doi: 10.1111/j.1399-0004.2010.01459.x.

PMID:
20597919
20.

Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.

Strasberg PM, Clarke JT.

Clin Chem. 1992 Nov;38(11):2249-55. Erratum in: Clin Chem 1993 Feb;39(2):371.

Supplemental Content

Support Center